These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 17979166)

  • 1. Light activation of anti-CD3 in vivo reduces the growth of an aggressive ovarian carcinoma.
    Thompson S; Stewart R; Smith JA; Self CH
    ChemMedChem; 2007 Nov; 2(11):1591-3. PubMed ID: 17979166
    [No Abstract]   [Full Text] [Related]  

  • 2. The construction and in vitro testing of photo-activatable cancer targeting folated anti-CD3 conjugates.
    Thompson S; Dessi J; Self CH
    Biochem Biophys Res Commun; 2008 Feb; 366(2):526-31. PubMed ID: 18068664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
    Tomsová M; Melichar B; Sedláková I; Steiner I
    Gynecol Oncol; 2008 Feb; 108(2):415-20. PubMed ID: 18037158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD137 enhances cytotoxicity of CD3(+)CD56(+) cells and their capacities to induce CD4(+) Th1 responses.
    Zhu BQ; Ju SW; Shu YQ
    Biomed Pharmacother; 2009 Aug; 63(7):509-16. PubMed ID: 19019623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some characteristics and purification of anti-(human ovarian carcinoma)xanti-(human CD3) single-chain bispecific antibody.
    Zhou F; Wei DZ; Tong WY; Zhu YQ; Jiang YM
    Biotechnol Appl Biochem; 2007 May; 47(Pt 1):39-47. PubMed ID: 17117923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired interleukin-2 synthesis and T cell proliferation following antibody-mediated CD3 and CD2 or CD28 cross-linking in trans: evidence that T cell activation requires the engagement of costimulatory molecules within the immunological synapse.
    Watson CL; Furlong SJ; Hoskin DW
    Immunol Invest; 2008; 37(1):63-78. PubMed ID: 18214800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes.
    Keller S; König AK; Marmé F; Runz S; Wolterink S; Koensgen D; Mustea A; Sehouli J; Altevogt P
    Cancer Lett; 2009 Jun; 278(1):73-81. PubMed ID: 19188015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
    Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.
    Sasaki N; Yamashita T; Takeda M; Shinohara M; Nakajima K; Tawa H; Usui T; Hirata K
    Circulation; 2009 Nov; 120(20):1996-2005. PubMed ID: 19884470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-localized ligation of CD3 and CD28 with systemic regulatory T-cell depletion induces potent innate and adaptive antitumor responses.
    Lee CH; Chiang YH; Chang SE; Chong CL; Cheng BM; Roffler SR
    Clin Cancer Res; 2009 Apr; 15(8):2756-66. PubMed ID: 19318495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel humanized anti-CD3 antibodies induce a predominantly immunoregulatory profile in human peripheral blood mononuclear cells.
    Silva HM; Vieira PM; Costa PL; Pimentel BM; Moro AM; Kalil J; Maranhão AQ; Coelho V; Brigido MM
    Immunol Lett; 2009 Aug; 125(2):129-36. PubMed ID: 19573559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells.
    Perruche S; Zhang P; Liu Y; Saas P; Bluestone JA; Chen W
    Nat Med; 2008 May; 14(5):528-35. PubMed ID: 18438416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Products of anti-CD3/anti-CD28 activated lymphocytes induce differentiation and maturation of dendritic cells and have adjuvant-like activity in vitro and in vivo.
    Harris KM; Lenz P; Hankey KG; MacVittie T; Farese A; Nakajima K; Hasumi K; Mann DL
    Clin Immunol; 2008 Oct; 129(1):58-68. PubMed ID: 18691939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target specificity of 188Re-labeled B27.1 monoclonal antibodies to ovarian cancer cells in vivo.
    Palakurthi S; Wilson J; McQuarrie SA; Suresh MR; Mercer JR; Miller GG
    In Vivo; 2008; 22(3):321-6. PubMed ID: 18610743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent control of tumor growth by CEA/CD3-bispecific single-chain antibody constructs that are not competitively inhibited by soluble CEA.
    Lutterbuese R; Raum T; Kischel R; Lutterbuese P; Schlereth B; Schaller E; Mangold S; Rau D; Meier P; Kiener PA; Mulgrew K; Oberst MD; Hammond SA; Baeuerle PA; Kufer P
    J Immunother; 2009 May; 32(4):341-52. PubMed ID: 19342971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells.
    Zappasodi R; Di Nicola M; Carlo-Stella C; Mortarini R; Molla A; Vegetti C; Albani S; Anichini A; Gianni AM
    Haematologica; 2008 Oct; 93(10):1523-34. PubMed ID: 18728033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian carcinoma cells influence differentiation of Lin-CD45RA- dendritic cell precursors into two mature subtypes in vitro.
    Chen LL; Ye F; Yu Y; Chen HZ; Zhang WW; Lü WG; Xie X
    Gynecol Oncol; 2009 Jan; 112(1):199-204. PubMed ID: 19022493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiolabeled humanized anti-CD3 monoclonal antibody visilizumab for imaging human T-lymphocytes.
    Malviya G; D'Alessandria C; Bonanno E; Vexler V; Massari R; Trotta C; Scopinaro F; Dierckx R; Signore A
    J Nucl Med; 2009 Oct; 50(10):1683-91. PubMed ID: 19759100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of ovarian UT-OC-2 carcinoma cells by cytokines: effects on cell proliferation, activation of transcription factors and apoptosis.
    Seppänen M; Lin L; Saarinen R; Punnonen R; Vihko KK
    Acta Obstet Gynecol Scand; 2008; 87(9):902-9. PubMed ID: 18720042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential roles of TGF-beta in anti-CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of Foxp3+CD4+ regulatory T cells.
    Chen G; Han G; Wang J; Wang R; Xu R; Shen B; Qian J; Li Y
    J Leukoc Biol; 2008 Feb; 83(2):280-7. PubMed ID: 18029395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.